Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits

Biomedicine and Pharmacotherapy

Volumn 63, Issue 7, 2009, Pages 457-462

  Xing, Wei Wei ^a,b   Wu, Jin Zhong ^c   Jia, Min ^a   Du, Jian ^a   Zhang, Hong ^a   Qin, Lu Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Hyperlipidemia; Polydatin; Polygonum cuspidatum; Rabbit

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYDATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; FAT INTAKE; HYPERLIPIDEMIA; LIPID ANALYSIS; LIVER PROTECTION; LOW DRUG DOSE; MALE; NONHUMAN; POLYGONUM CUSPIDATUM; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BODY WEIGHT; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; GLUCOSIDES; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; POLYGONUM CUSPIDATUM; RABBITS; STILBENES; TRIGLYCERIDES;

EID: 68049084636     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.06.035     Document Type: Article

References (28)

1. Afilalo J., Duque G., Steele R., Jukema J.W., de Craen A.J., and Eisenberg M.J. Statins for secondary prevention in elderly patients: a hierarchical Bayesian meta-analysis. J Am Coll Cardiol 51 (2008) 37-45
2. Elam M.B., Hunninghake D.B., Davis K.B., Garg R., Johnson C., Egan D., et al. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease. The ADMIT study: a randomized trial. JAMA 284 (2000) 1263-1270
3. Grundy S.M., Vega G.L., McGovern M.E., Tulloch B.R., Kendall D.M., Fitz-Patrick D., et al. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial. Arch Intern Med 162 (2002) 1568-1576
4. Brown B.G., Zhao X.Q., Chait A., Fisher L.D., Cheung M.C., Morse J.S., et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345 (2001) 1583-1592
5. Chen H.B., Feng R.Z., Guo Y., Sun L.H., and Jiang J. Hypoglycemic effects of aqueous extract of Rhizoma Polygonati Odorati in mice and rats. J Ethnopharmacol 74 (2001) 225-229
6. Lee H.S., Yoo C.B., and Ku S.K. Hypolipemic effect of water extracts of Picrorrhiza kurroa in high fat diet treated mouse. Fitoterapia 77 (2006) 579-584
7. Khanna A.K., Rizvi F., and Chander R. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J Ethnopharmacol 82 (2002) 19-22
8. Herrera-Arellano A., Aguilar-Santamaria L., Garcia-Hernandez B., Nicasio-Torres P., and Tortoriello J. Clinical trial of Cecropia obtusifolia and Marrubium vulgare leaf extracts on blood glucose and serum lipids in type 2 diabetics. J Phytomed 11 (2004) 561
9. Shan B., Cai Y.Z., Brooks J.D., and Corke H. Antibacterial properties of Polygonum cuspidatum roots and their major bioactive constituents. Food Chem 109 (2008) 530-537
10. Pan Y.M., Zhang X.P., Wang H.S., Liang Y., Zhu J.C., Li H.Y., et al. Antioxidant potential of ethanolic extract of Polygonum cuspidatum and application in peanut oil. Food Chem 105 (2007) 1518-1524
11. Wang S.S., Zheng Z.G., Weng Y.Q., Yu Y.J., Zhang D.F., Fan W.H., et al. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci 74 (2004) 2467-2478
12. Jiang Q.L., Li Y.Y., Pan J.Y., Ma J., Xu B.L., Yang H., et al. TNF-alpha gene expression of NAFLD rat intervened by the extracts of Rizoma Polygoni Cuspidati. J Chin Med Mater 28 (2005) 917-920
13. Cheng Y.F., Zhang H.T., Sun L.S., Guo S.L., Ouyang S., Zhang Y.J., et al. Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury. Brain Res 1110 (2006) 193-200
14. Jordan K.C., Freeland-Graves J.H., Klohe-Lehman D.M., Cai G.W., Voruganti V.S., Proffitt J.M., et al. A nutrition and physical activity intervention promotes weight loss and enhances diet attitudes in low-income mothers of young children. Nutr Res 28 (2008) 13-20
15. Huang Z.S., Wang Z.W., Liu M.P., Zhong S.Q., Li Q.M., and Rong X.L. Protective effects of polydatin against CCl(4)-induced injury to primarily cultured rat hepatocytes. World J Gastroenterol 5 (1999) 41-44
16. Huang J., Yang D., Gao S., and Wang T. Effects of soy-lecithin on lipid metabolism and hepatic expression of lipogenic genes in broiler chickens. Livest Sci (2008) 10.1016/j.livsci.2008.01.014
17. Kannel W.B., Castelli W.P., and Gordon T. Cholesterol in the prediction of atherosclerotic disease. Ann Inter Med 90 (1979) 85-91
18. Lee H.S., Ahn H.C., and Ku S.K. Hypolipemic effect of water extracts of Picrorrhiza rhizoma in PX-407 induced hyperlipemic ICR mouse model with hepatoprotective effects: a prevention study. J Ethnopharmacol 105 (2006) 380-386
19. Morishita S., Saito T., Mishima Y., Mizutani A., Hirai Y., Koyama S., et al. Strains and species differences in experimental hyperlipidemia. Nippon Yakugaku Zasshi 87 (1986) 259-264
20. Wang Z.Q., Zuberi A.R., Zhang X.H., Macgowan J., Qin J., Ye X., et al. Effects of dietary fibers on weight gain, carbohydrate metabolism, and gastric ghrelin gene expression in mice fed a high-fat diet. Metabolism 56 (2007) 1635-1642
21. Lal J.J., Sreeranjit Kumar C.V., Suresh M.V., Indira M., and Vijayammal P.L. Effect of in utero exposure of toddy (coconut palm wine) on liver function and lipid metabolism in rat fetuses. Plant Food Hum Nutr 52 (1998) 209-219
22. Hoyos M., Guerrero J.M., Perez-Cano R., Olivan J., Fabiani F., Garcia-Perganeda A., et al. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats. J Pineal Res 28 (2000) 150-155
23. Mukai M., Ozasa K., Hayashi K., and Kawai K. Various S-GOT/S-GPT ratios in nonviral liver disorders and related physical conditions and life-style. Digest Dis Sci 47 (2002) 549-555
24. Nofer J.R., Kehrel B., Fobker M., Levkau B., Assmann G., and von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161 (2002) 1-16
25. Cheng J.W. Rosuvastatin in the management of hyperlipidemia. Clin Ther 26 (2004) 1368-1387
26. Boers M., Nurmohamed M.T., Doelman C.J., Lard L.R., Verhoeven A.C., Voskuyl A.E., et al. Influence of glucocorticoid and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 62 (2003) 842-845
27. Situnayake R., and Kitas G. Dyslipidemia and rheumatoid arthritis. Ann Rheum Dis 56 (1997) 341-342
28. Parthasarathy S., Barnett J., and Fong L.G. High density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochim Biophys Acta 1044 (1990) 275-283